The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study

van Kessel Kim E.; Zwarthoff Ellen C.

首页> 外文期刊>Urology >The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study

【24h】

The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study

机译：膀胱FGFR3尿FGFR3突变分析的诊断和预后性能：前瞻性多中心研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Urology》 |2015年第6期|共2页
作者
van Kessel Kim E.; Zwarthoff Ellen C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study [J] . Couffignal Camille, Desgrandchamps Francois, Mongiat-Artus Pierre, Urology . 2015,第6期

机译：膀胱FGFR3尿FGFR3突变分析的诊断和预后性能：前瞻性多中心研究
2. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study REPLY [J] . The Journal of Urology . 2017,第6期

机译：FGFR3，TERT和OTX1作为尿生物标志物组合，用于在大型前瞻性多中心研究回复中进行膀胱癌患者的监测
3. FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study [J] . Beukers Willemien, van der Keur Kirstin A., Kandimalla Raju, The Journal of Urology . 2017,第6期

机译：FGFR3，TERT和OTX1作为尿生物标志物组合，用于在大型前瞻性多中心研究中进行膀胱癌患者的监测
4. PROSPECTIVE TRIAL OF 5-AZACITIDINE IN DOGS WITH NATURALLY-OCCURRING INVASIVE URINARY BLADDER CANCER, AN EPIGENETIC APPROACH TO CANCER THERAPY. [C] . Noah Hahn, Deborah Knapp, Michael Childress, Annual Conference of the Veterinary Cancer Society . 2009

机译：患有自然侵袭性膀胱癌的5-氮杂氨酸的前瞻性试验，癌症治疗的表观遗传方法。
5. Cystoscopy and the development of invasive bladder cancer in patients presenting with superficial urinary bladder cancer. [D] . Amos, Charles E., Jr. 2003

机译：膀胱镜检查和浅表性膀胱癌患者的浸润性膀胱癌的发展。
6. Promoter hypermethylation of HS3ST2 SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer [O] . Jean-Pierre Roperch, Bernard Grandchamp, François Desgrandchamps, 2016

机译：HS3ST2SEPTIN9和SLIT2的启动子高甲基化结合FGFR3突变作为敏感性/特异性尿液测定法可用于低或高风险非肌肉浸润性膀胱癌患者的诊断和监测
7. Supplementary Material for: Promoter hypermethylation of HS3ST2, SEPTIN9 and SLIT2 combined with FGFR3 mutations as a sensitive/specific urinary assay for diagnosis and surveillance in patients with low or high-risk non-muscle-invasive bladder cancer [O] . Roperch, Jean-Pierre, Grandchamp, Bernard, Desgrandchamps, François, 2016

机译：补充材料：HS3ST2，SEPTIN9和SLIT2的启动子高甲基化结合FGFR3突变，作为敏感/特异的尿液测定法，可用于低危或高危非肌肉浸润性膀胱癌患者的诊断和监测

The Diagnostic and Prognostic Performance of Urinary FGFR3 Mutation Analysis in Bladder Cancer Surveillance: A Prospective Multicenter Study

著录项

相似文献

相关主题

期刊订阅